INTERDISCIPLINARITATE

Anorexia nervoasă şi microbiomul intestinal

 Anorexia nervosa and gut microbiota

Anca Mihaela Hâncu

First published: 24 iunie 2019

Editorial Group: MEDICHUB MEDIA

DOI: 10.26416/Psih.57.2.2019.2443

Abstract

Gut microbiota is playing an important role for host health. Gut-brain axis, defined by new research, is the bidirectional communication between brain and intestinal microbiota. Anorexia nervosa (AN) is defined as the mental ilness characterized by high restriction in energy intake, with a very low weight and terrible fear of weight increase. The disruption of normal gut microbiota, defined as a dysbiosis, is described in AN. Microbiota modulation could bring health benefits, with practical applicability in AN. The new psychobiotics may improve mood, decrease anxiety and strengthen memory, as described in preliminary findings that are suggesting near future treatment with probiotics/psychobiotics to treat mental disorders, used in supplements or food to change gut microbiome. The personalised psychobiotics approach is the future perspective.

Keywords
gut-microbiota axis, gut microbiota, anorexia nervosa, psychobiotics, eating disorders, dysbiosis

Rezumat

Microbiomul intestinal joacă un rol‑cheie pentru organismul gazdă. Axa cerebrointestinală, definită de cercetări noi, este o cale bidirecţională de comunicare între creier şi microbiomul intestinal. 
Anorexia nervoasa (AN) este definită ca o boală mintală caracterizată prin restricţie drastică a aportului energetic, cu o greutate corporală foarte scăzută şi frică teribilă de a câştiga din nou în greutate. În AN se descrie perturbarea microbiomului intestinal normal, definită ca o disbioză. Modularea microbiotei poate aduce beneficii pentru sănătate, cu aplicabilitate practică în AN. 
Psihobioticele pot ameliora dispoziţia, pot scădea anxietatea şi îmbunătăţi memoria, aşa cum s-a descris în studii preliminare, astfel că se sugerează tratamente în viitorul apropiat cu probiotice/psihobiotice pentru tratarea bolilor mintale, folosite în suplimente sau alimente pentru a schimba microbiomul intestinal. Abordarea cu psihobiotice personalizate va fi perspectiva de viitor.  

Introduction

Anorexia nervosa (AN) is defined by Diagnostic and Statistical Manual of Mental Disorders (DSM 5) as a mental illness characterised by a high restriction in energy intake, with a very low weight and terrible fear of weight increase. The AN classification is: restrictive and compulsive. In the restrictive mode, patients will describe during past three months laxatives abuse, vomiting, and diuretics use. The compulsive type is an alternation of binge eating and purging(1). The main target in AN is weight recovery. This will be mandatory for the prevention of psychological or somatic sequelae(2).

Gut microbiota plays more and more a recognised role for the host and is constituted of different microorganisms, living in symbiosis with the host. The microbiota is specific and unique for each person, the composition being like a fingerprint(3). Along the intestine, microbiota’s changes in density and composition are affected by nutritional, immunological and chemical factors. In fact, these bacterial communities will be found in the colon(4). A disruption of the normal gut microbiota, defined as dysbiosis, is described in AN.

The brain-gut axis: implications in anorexia nervosa

The bidirectional communication system between the host brain and the gut is defined as the brain-gut axis. The regulatory mechanisms are immunological, endocrine and neural systems, microbiota playing a key role(5,6). The communication to the nervous system is through ENS- enteric nervous system. The role of these connections is to control and coordinate motility, mucosal transport, blood flow and secretions in the gastrointestinal tract, with direct influence on the composition of gut microbiota. Motor neurons act as effector cells in the gastrointestinal tract(7). The connection between CNS and ENS is realised by the vagus nerve, creating neurochemical signals via gut microbiota to the brain(8) and back from nervous system to gut microbiota(9).

The observation from animal studies reveals that, in the absence of microbiota, an abnormal hypothalamic pituitary adrenal axis will be developed, with effect on releasing cortisol, the stress-induced hormone(10).

An important effect of gut microbiota can be seen on thyroid and sexual hormones, coordinating hormones and peptides release that are involved in feeding behaviour and in energy balance(11). It can be assumed that microbiota organisms will be able to influence host food habits and also emotional behaviour, influencing molecule secretion(12). It is interesting that bacteria can communicate on the other side with host’s brain, because they have receptors for hormones(13). Gamma aminobutyric acid (GABA) is the neurotransmitter that reduces stress and anxiety, and Bifidobacteria and Lactobacillus are able to synthetize this neurotransmitter(14). Norepinephrine is produced by Bacillus, Saccharomyces and Escherichia(14). Moreover, Streptococcus, Candida, Enterococcus and Escherichia produce serotonin, while Serratia and Bacillus are producing dopamine, which could be considered the major CNS disruptor(15).

Butyrate acid is produced by gut microbiota, and its beneficial effects in the brain are well known(16). Butyrate acid is a short chain fatty acid resulted after fibres bacterial fermentation in colon and can improve brain health.

Practically, microbiota could be seen as a recruiter for bidirectional communication between the gut and the brain and is a modulator for brain development, behaviour and function(17).

Alcock and Maley(18) suggest that gut microbiota can control the preference for food and our appetite. In anorexia nervosa, the main features are:

  • A dysbiosis due to decreased propionate, acetate, butyrate and short chain fatty acids.

  • Neuroinflammation:

    • dysregulation in the immune system;

    • leaky gut theory, when the brain-blood barrier is damaged and  molecules produced by microbiota (IL-6 and LPS) will cross the barrier and will produce neuroinflammation;

    • the immune cells are under microbiota control(19);

    • in neuroinflammation and neurodegeneration, it can be seen the involvement of microglia, too.

Eating disorders are associated with an neuroendocrine and neuropeptide dysregulation(20), but still some mechanisms behind AN need to be elucidated. In AN, it has been described the dysregulation of the entire endocrine system, including appetite regulation hormones and adipokines(21). New data are associating the dysregulation of serotonin pathways with behavioural inhibition, anxiety and distorsions of the body image, described in AN(22). It is well known that psychological stress can induce microbiota changes(23). Stress is positively correlated with Camphylobacter(24) and negatively with Lactobacillus(25).

Dysbiosis in anorexia nervosa patients

Dysbiosis is defined as a disruption of the normal gut microbiota composition and is associated with different diseases. Dysbiosis can be described by the lack of beneficial bacteria, pathobionts presence and low microbial diversity. A growing number of diseases are associated with dysbiosis: obesity(26), asthma(27) and neuropsychiatric disorders (schizophrenia, psychotic disorders, autism spectrum disorder, Alzheimer disease, Parkinson disease, major depressive disorders and anorexia nervosa)(28-37).

The gut microbial dysbiosis is associated with anorexia nervosa and is marked by taxonomic differences and lower microbial diversity versus healthy controls. Dysbiosis is accompanied by eating disorders and depression psychopathology(38). There was an interesting result found in another study, where microbial composition was evaluated before and after weight regain in AN, showing profound differences in microbiota which didn’t recover after weight gain(39). Reduced levels of butyrate, and also decreased Bacteroidetes/Firmicutes ratio were described in AN patients, before and after weight gain.

Recent evidence(40) are describing dysbiosis in AN: lower alpha diversity, increase in Turcibacter, Anacrotruncus, Salmonella and Klebsiella, and decrease in Eubacterium, Anacrostipes, Roseburia and Peptostreptococcaceae.

Microbiota modulation

The neurodevelopment is related to genetic expression and environmental factors coordination. The development of social behaviour, emotions and cognitions requires precise regulation and molecular signalling pathways are involved together with the microbiome-gut-brain axis(41,42).

All evidence about gut microbiota in psychiatric disorders are suggesting that an intervention is needed on gut microbiota. How microbiome could be modulated? Antibiotics, probiotics, prebiotics or fecal microbiome transplantations (FMT) are possible interventions. The International Scientific Association for Probiotics and Prebiotics (ISAPP) defines probiotics as living organisms that, when administered in adequate quantities, confer benefits for host health(43). ISAPP scientific panel is confirming that probiotics help in having a healthy digestive tract, emphasizing general benefits of probiotics for gut microbiota.

Increasing interest, due to promising study results(44,45), is attributed to probiotics, live bacteria which could confer health benefits when the intake is adequate. Behavioural abnormalities could be improved by Lactobacillus strains(46) and evidence are showing that other probiotics are improving emotions(47). There are described probiotic bacteria with positive outcomes on mental health benefits, which associated with prebiotics will be named psychobiotics. Human gut has a unique bacterial colonization and will influence the clinical presentation of patients with stress-related or affective disorders. In the future, personalised psychobiotics could play an important role in modulating dysbiosis in AN.

All these suggested that treatments with probiotics in AN must be managed carefully, because is a high risk of bacterial infections and need to be in accordance with nutritional rehabilitation(48), having as target psychological functions restoration and reversing malnutrition. The existing data are revealing that in AN gut microbial diversity is increasing after refeeding.

Using functional foods, with the potential of modulation for gut-brain axis, influencing mental health, is a novel and interesting topic. Fermented foods, due to important health benefits, are considered functional foods.

Immune mechanisms in the regulation of metabolism and food intake

The chronic food restriction in AN may lead to gut barrier dysfunction, contributing to different diseases. Many changes in immune reactivity are described in anorexia nervosa: increased release of TNF-(49) and decrease of interferon gamma by mononuclear cells(49), decreased cell-mediated cytotoxicity, increased serum levels of IL-6, IL-2 and transforming growth factor beta (TGF-)(50), cross-reacting autoantibodies reacting specifically with several appetite regulating peptides(51), the association between eating disorders and several autoimmune diseases(52), the association of autoimmune and antiinflammatory diseases with increased risk of eating disorders(53). Starvation will lead to a “leaky gut”, and increased mucin-degrading bacteria will influence chronic low-grade inflammation expected in AN patients. Anorexia nervosa is an autoimmune disease – it is an hypothesis elaborated by Acres et al., named “hygiene hypothesis”, and is produced by a delayed exposure to microorganisms that are common and then autoantibodies are produced for appetite regulating neurotransmitters, neuropeptides and hypothalamic neurons that disturb completely the appetite and, as a result, it decreases the food intake(54)

Microbiota patterns – the role of lifestyle

AN etiology is complex. The healthy state depends on interactions between environmental factors and genetics. Culbert et al. are suggesting that psychological and environmental factors could potentiate the genetic risk and induce eating disorder(55).

Gut microbiota is influenced by lifestyle factors, both dietary and not dietary, but for AN patients there are not many data available. The disordered feeding behaviours such as vomiting and laxative abuse are part of an unhealthy lifestyle. Unhealthy feeding behaviour and lifestyle could lead to AN – this is a discussed subject. Practically, the obsession for a very low weight(56) is accompanied by inappropriate lifestyle practices, with direct influence on microbiota. It is well known that patients with anorexia nervosa avoid carbohydrates and increase protein intake, especially of animal origin. With smaller fibres intake, short chain fatty acids (SCFAs) formed are in smaller quantity and microbiota composition will be altered. Due to fatty acids imbalance, insulin resistance and metabolic dysfunctions will be relevant in eating disorders(57). A common comorbidity for patients with AN is the anxiety disorder(58).

A relation with this comorbidity and inflammation has been established in animal studies. Some stressors can induce microbial translocation, generating gut inflammation, maybe the link between microbiota changes in AN and its onset(59).

Despite the fact that inflammation biomarkers are not changed in severe AN cases(60), commensal microbiota typical in inflammation is changed in AN patients(57).

In addition, hyperproteic diets used for refeeding could develop a type of microbiota characterised by inflammatory profile(61). Probably, microbiota changes in AN from the onset to the first stages could give more details about different implications in eating disorder progression. The neurodevelopment can be influenced by early life perturbations and it could be responsible for different mental disorders that appear later in life. At this point, lifestyle-based therapeutic interventions could prevent future brain disorders(62).

Conclusions 

Human microbiome detailed analysis was possible due to advanced techniques in molecular biology. It is generally accepted the role of microbiota in diseases and health. In recent years, studies on anorexia nervosa and microbiota emerged. Significant changes in gut composition are associated with behavioural disorders, mainly eating disorders.

In anorexia nervosa, the biomarker for disease onset and progression can be considered increased M. smithii.

The recommended intervention will be to restore microbiota, which is impaired in AN, considering the intake of pro-/prebiotics, or  fecal microbiota transplantation.

In AN, psychiatric intervention should be initiated as early as possible and, after analyzing the available data, microbiota could be a starting point and should be included in nutritional intervention as part of a rehabilitation program. The whole protocol must include refeeding under specialised control, increase dietary fibres, and including in the diet pro-/prebiotics. New psychobiotics may improve mood, decrease anxiety and strengthen memory, as described in preliminary findings. In the near future, anxiety, depression or other mental disorders may be treated with probiotics/psychobiotics, using them in food or supplements to change gut microbiome(63).

The personalised psychobiotics approach will be the future perspective.  

Bibliografie

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., American Psychiatric Publishing, Inc.: Washington, DC, USA, 2013.
  2. Herpertz-Dahlmann B, Seitz J, Baines J. Food matters: how the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa. Eur. Child Adolesc. Psychiatry. 2017; 26,1031–1041. 
  3. Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr. Rev. 2012; 70, S38–S44. 
  4. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; 474, 1823–1836. 
  5. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012; 10, 735–742. 
  6. Gacias M, Gaspari S, Santos PMG, Tamburini S, Andrade M, Zhang F, Shen N, Tolstikov V, Kiebish MA, Dupree JL, et al. Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior. Elife. 2016; 5, e13442. 
  7. Al Omran Y, Aziz Q. The brain-gut axis in health and disease. Adv. Exp. Med. Biol. 2014; 817, 135–153.
  8. Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015; 17, 565–576. 
  9. Bonaz B, Bazin T, Pellissier S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci. 2018; 12, 49. 
  10. Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv. Exp. Med. Biol. 2014; 817, 177–194. 
  11. Neuman H, Debelius JW, Knight R, Koren O. Microbial endocrinology: The interplay between the microbiota and the endocrine system. FEMS Microbiol. Rev. 2015; 39, 509–521.
  12. Morita C, Tsuji H, Hata T, Gondo M, Takakura S, Kawai K, Yoshihara K, Ogata K, Nomoto K, Miyazaki K, et al. Gut Dysbiosis in Patients with Anorexia Nervosa. PLoS ONE. 2015; 10, e0145274.
  13. Bailey MT. Influence of Stressor-Induced Nervous System Activation on the Intestinal Microbiota and the Importance for Immunomodulation. Adv. Exp. Med. Biol. 2014; 817, 255–276. 
  14. Dehhaghi M, Kazemi Shariat Panahi H, Guillemin GJ. Microorganisms’ Footprint in Neurodegenerative Diseases. Front. Cell Neurosci. 2018; 12, 466. 
  15. Evrensel A, Ceylan ME. The gut-brain axis: The missing link in depression. Clin. Psychopharmacol. Neurosci. 2015; 13, 239–244. 
  16. Bourassa MW, Alim I, Bultman SJ, Ratan RR. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?. Neurosci. Lett. 2016; 625, 56–63. 
  17. Dinan TG, Cryan JF. Gut instincts: Microbiota as a key regulator of brain development, ageing and neurodegeneration. J. Physiol. 2017; 595, 489–503. 
  18. Alcock J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays. 2014; 36, 940–949. 
  19. Knoop KA, Gustafsson JK, McDonald KG, Kulkarni DH, Coughlin PE, McCrate S, Kim D, Hsieh CS, Hogan SP, Elson CO, et al. Microbial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria. Sci. Immunol. 2017; 2, eaao1314. 
  20. Bailer U, Kaye W. A Review of Neuropeptide and Neuroendocrine Dysregulation in Anorexia and Bulimia Nervosa. Curr. Drug Targets CNS Neurol. Disord. 2003; 2, 53–59. 
  21. Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: Mechanisms and management. Nat. Rev. Endocrinol. 2017; 13, 174–186. 
  22. Bailer UF, Kaye WH. Serotonin: Imaging findings in eating disorders. Curr. Top. Behav. Neurosci. 2011; 6, 59–79. 
  23. Kleiman SC, Watson HJ, Bulik-Sullivan EC, Huh EY, Tarantino LM, Bulik CM, Carroll IM. The Intestinal Microbiota in Acute Anorexia Nervosa and during Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom. Med. 2015; 77, 969–981. 
  24. Indikova I, Humphrey TJ, Hilbert F. Survival with a helping hand: Campylobacter and microbiota. Front. Microbiol. 2015; 6, 1266. 
  25. Galley JD, Nelson MC, Yu Z, Dowd SE, Walter J, Kumar PS, Lyte M, Bailey MT. Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol. 2014; 14, 189. 
  26. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014; 588:4223e33.
  27. Azad MB, Kozyrskyj AL. Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol. 2012; 932072.
  28. Borgo F, Riva A, Benetti A, Casiraghi MC, Bertelli S, et al. Microbiota in anorexia nervosa: the triangle between bacterial species, metabolites and psychological tests. PLoS One. 2017; 12:e0179739.
  29. Morita C, Tsuji H, Hata T, Gondo M, Takakura S, et al. Gut dysbiosis in patients with anorexia nervosa. PLoS One. 2015;10.
  30. Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, et al. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord. 2016; 202:254e7.
  31. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015; 48:186e94.
  32. Castro-Nallar E, Bendall ML, Perez-Losada M, Sabuncyan S, Severance EG, et al. Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. Peer J. 2015; 3:e1140.
  33. Schwarz E, Maukonen J, Hyytiainen T, Kieseppa T, Oresic M, et al. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res. 2018; 192: 398e403.
  34. Pulikkan J, Maji A, Dhakan DB, Saxena R, Mohan B, et al. Gut microbial dysbiosis in Indian children with autism spectrum disorders. Microb Ecol. 2018 Nov; 76(4):1102-1114. 
  35. Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017; 5:24.
  36. Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017; 7:13537.
  37. Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, et al. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 2015; 30:1351e60.
  38. Kleiman SC, Watson HJ, Bulik-Sullivan EC, Huh EY, Tarantino LM, et al. The intestinal microbiota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and eating disorder psychopathology. Psychosom Med. 2015; 77:969e81.
  39. Mack I, Cuntz U, Gramer C, Niedermaier S, Pohl C, et al. Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints. Sci Rep. 2016; 6:26752.
  40. Hanachi M, Bohem V, Bemer P, Kayser N, de Truchis P, Melchior J.-C. Negative role of malnutrition in cell-mediated immune response: Pneumocystis jirovecii pneumonia (PCP) in a severely malnourished, HIV-negative patient with anorexia nervosa. Clin Nutr ESPEN. 2018; 25, 163–165. 
  41. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatr. 2013;18:666e73.
  42. Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2017; 595:489e503.
  43. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014; 11, 506–514.
  44. Kelly JR, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbiota axis: challenges for translation in psychiatry. Ann Epidemiol. 2016; 26:366e72.
  45. Kelly JR, Minuto C, Cryan JF, Clarke G, Dinan TG. Cross talk: the microbiota and neurodevelopmental disorders. Front Neurosci. 2017; 11:490.
  46. Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: A systematic review. Ann. Gen. Psychiatry. 2017; 16, 14. 
  47. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 2015; 48, 258–264.
  48. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev.Gastroenterol. Hepatol. 2017; 14, 491. 
  49. Schattner A, Tepper R, Steinbock M, Hahn T, Schoenfeld A. TNF, interferon-gamma and cell-mediated cytotoxicity in anorexia nervosa. Effect of refeeding.
  50.  J Clin Lab Immunol. 1990; 32:183e4.
  51. Pomeroy C, Eckert E, Hu S, Eiken B, Mentink M, et al. Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol Psychiatry. 1994; 36:836e9.
  52. Fetissov SO, Harro J, Jaanisk M, Jarv A, Podar I, et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA. 2005; 102:14865e70.
  53. Wotton CJ, James A, Goldacre MJ. Coexistence of eating disorders and autoimmune diseases: record linkage cohort study, UK. Int J Eat Disord. 2016; 49:663e72.
  54. Zerwas S, Larsen JT, Petersen L, Thornton LM, Quaranta M, et al. Eating disorders, autoimmune, and autoinflammatory disease. Pediatrics. 2017; 140.
  55. Acres MJ, Heath JJ, Morris JA. Anorexia nervosa, autoimmunity and the hygiene hypothesis. Med Hypotheses. 2012; 78:772e5. 
  56. Culbert KM, Racine SE, Klump KL. Research Review: What we have learned about the causes of eating disorders. A synthesis of sociocultural, psychological, and biological research. J. Child. Psychol. Psychiatry. 2015, 56, 1141–1164. 
  57. Lladó G, González-Soltero R, Blanco Fernández de Valderrama MJ, Lladó G, González-Soltero R, Blanco MJ. Anorexia y bulimia nerviosas: Difusión virtual de la enfermedad como estilo de vida. Nutr. Hosp. 2017; 34, 693. 
  58. Lam YY, Maguire S, Palacios T, Caterson ID. Are the gut bacteria telling us to eat or not to eat? Reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders. Nutrients. 2017; 9, 602. 
  59. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbidity of Anxiety Disorders With Anorexia and Bulimia Nervosa. Am. J. Psychiatry. 2004; 161, 2215–2221. 
  60. Rieder R, Wisniewski PJ, Alderman BL, Campbell .C. Microbes and mental health: A review. Brain Behav. Immun. 2017; 66, 9–17. 
  61. Dalton B, Campbell I, Chung R, Breen G, Schmidt U, Himmerich H. Inflammatory Markers in Anorexia Nervosa: An Exploratory Study. Nutrients. 2018; 10, 1573. 
  62. Herpertz-Dahlmann B, Seitz J, Baines J. Food matters: How the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa. Eur. Child Adolesc. Psychiatry. 2017; 26,1031–1041. 
  63. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: Implications for brain disorders. Trends Mol. Med. 2014;
  64. Bermúdez-Humarán LG, Salinas E, Ortiz GG, Ramirez-Jirano LJ, Morales JA, Bitzer-Quintero OK. From Probiotics to Psychobiotics: Live Beneficial Bacteria Which Act on the Brain-Gut Axis. Nutrients. 2019; 11(4), 20, 509–518.